Sources | Names Used |
---|---|
CTRPv2 | JQ-1:navitoclax (2:1 mol/mol) |
PharmacoGx | JQ-1:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | C16orf92 | CTRPv2 | pan-cancer | AAC | 0.14 | 5e-05 |
mRNA | INA | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-05 |
mRNA | SHISA7 | CTRPv2 | pan-cancer | AAC | 0.14 | 5e-05 |
mRNA | RALGDS | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-05 |
mRNA | DPP10 | CTRPv2 | pan-cancer | AAC | 0.14 | 5e-05 |
mRNA | USP37 | CTRPv2 | pan-cancer | AAC | 0.14 | 5e-05 |
mRNA | LINGO1 | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-05 |
mRNA | PCDHA13 | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-05 |
mRNA | ZNF146 | CTRPv2 | pan-cancer | AAC | 0.14 | 5e-05 |
mRNA | CTSL | CTRPv2 | pan-cancer | AAC | -0.14 | 5e-05 |